In this episode, David Pivnick, Partner at McGuireWoods LLP, joins Scott Becker for a wide ranging conversation on MLB free agency, NBA roster building, NFL trade risks, and comeback stories.

In this episode, Scott Becker discusses the rise in unemployment to its highest level in more than 4 years.

In this episode, Scott Becker examines Oracle’s recent stock decline and what it may signal about AI investment, data center spending, and broader market risk.

In this episode, Scott Becker breaks down Ford’s nearly $19.5 billion writedown on its electric vehicle program and why the market has largely shrugged it off.

In this episode, Jeff Freedman discusses building strong teams, balancing strategy with daily execution, and the habits that drive long term success for CEOs and senior leaders.

In this episode, Scott Becker examines Elon Musk’s personal valuation crossing $600 billion, driven largely by SpaceX’s rising private market value and expectations for a future IPO.

In this episode, Holly Buckley, Chair of Healthcare at McGuireWoods LLP, shares insights on the J.P. Morgan Healthcare Conference, goal setting in a changing market, and what she is watching across healthcare and private equity. She also previews the upcoming McGuireWoods Healthcare Private Equity Conference and discusses priorities shaping dealmaking in the year ahead.

In this episode, Scott Becker breaks down the realities of consulting services, outlining when they truly add value, when they fall short as packaged products, and when they become costly and ineffective.

In this episode, Scott Becker examines whether Nvidia may still be undervalued despite being the world’s highest market cap company, strong free cash flow, and rapid revenue growth.

In this episode, Scott Becker breaks down Alphabet’s standout performance and also highlights their lesser known SpaceX investment.